Philadelphia, January 26, 2021 – Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania found female and male collegiate athletes take approximately the same amount of time to recover from a concussion, with subtle differences in recovery time depending on the type of sports being played and the division level of the…
A multidisciplinary team of researchers at the University of Massachusetts Amherst’s Institute for Applied Life Sciences (IALS) have developed a technique to replicate bone tissue complexity and bone remodeling processes. This breakthrough could help researchers further their study of bone biology and assist in improving development of drugs for osteoporosis. Published in Science Advances, the…
SAN ANTONIO and BOSTON – Study findings released Tuesday in the Journal of the American Medical Association (JAMA) hold both good news and bad news about transient ischemic attacks (TIAs), which are harbingers of subsequent strokes. Sudha Seshadri, MD, professor of neurology at The University of Texas Health Science Center at San Antonio and director…
STUDY PROFILES IMMUNE CELLS FIGHTING COVID-19, MAY HELP GUIDE NEXT-GEN VACCINE DEVELOPMENT Media Contact: Michael E. Newman, mnewma25@jhmi.edu Even as the first vaccines for SARS-CoV-2, the virus that causes COVID-19, are being distributed, scientists and clinicians around the world have remained steadfast in their efforts to better understand how the human immune system responds to…
JERUSALEM — Israel, which leads the world in vaccinating its population against the coronavirus, has produced some encouraging news: Early results show a significant drop in infection after just one shot of a two-dose vaccine, and better than expected results after both doses. Public health experts caution that the data, based on the Pfizer-BioNTech vaccine,…
As the coronavirus assumes contagious new forms around the world, two drug makers reported on Monday that their vaccines, while still effective, offer less protection against one variant and began revising plans to turn back an evolving pathogen that has killed more than two million people. The news from Moderna and Pfizer-BioNTech underscored a realization…
There are Covid-19 bubbles — small clusters of friends or family who agree to socialize exclusively with each other during the pandemic — and then there are the kinds of bubbles the Flaming Lips used at recent concerts. Band members and concertgoers rocked out and bounced while encased in large individual plastic bubbles amid bright…
SALISBURY, England — On a recent Saturday afternoon, Margaret Drabble, 83, sat beneath the soaring arches of Salisbury Cathedral, swinging her legs back and forth under her chair like a schoolgirl. Minutes earlier, in a booth near the cathedral’s entrance, she had received her first shot of the Pfizer-BioNTech vaccine against the coronavirus. But that…
Carolyn Zain had heard horror stories about the nation’s coronavirus vaccine rollout: long waits, clunky websites, people being turned away. So when her health department announced it was expanding appointments, she armed herself with two phones and held her breath. Within 20 minutes, she secured a slot for the next day. She arrived for her…
Scientists developed vaccines less than a year after Covid-19 was identified, a reflection of remarkable progress in vaccine technology. But progress in vaccine distribution is another story. Many questions that arose in vaccine rollouts decades ago are still debated today. How should the local and federal authorities coordinate? Who should get vaccinated first? What should…